Atlas Trials

Study to Evaluate the Safety and Anti-tumor Activity of SCC244

Clinical trial NCT03466268 · COMPLETED

Trial details

NCT number
NCT03466268
Sponsor
Haihe Biopharma Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Solid Tumor
Start date
2017-09-14
Primary completion
2023-01-09
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.